NCT04191577: A trial that was reported late by Cerevance Beta, Inc.
This trial has reported, although it was 234 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04191577 |
|---|---|
| Title | A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 2, 2019 |
| Completion date | Nov. 6, 2021 |
| Required reporting date | Nov. 6, 2022, midnight |
| Actual reporting date | June 28, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 234 |